MDWH vs. Cartilage-Hair Hypoplasia: What's the Difference?
At a Glance
MDWH and Cartilage-Hair Hypoplasia (CHH) are part of the same genetic spectrum caused by RMRP gene mutations. While MDWH patients do not have the sparse hair or early immune issues of CHH, both conditions carry long-term risks for immunodeficiency and cancer that require identical monitoring.
In this answer
3 sections
MDWH (Metaphyseal Dysplasia without Hypotrichosis) and typical Cartilage-Hair Hypoplasia (CHH) are different names for conditions caused by changes in the exact same gene, known as the RMRP gene [1][2]. Historically, doctors used the term MDWH for patients who had the skeletal features (bone growth issues) of CHH, but did not have the sparse, light-colored hair (hypotrichosis) or the severe immune system problems often seen in early childhood with classic CHH [1][2]. However, we now understand that MDWH is not a completely separate condition; it is part of the CHH spectrum [1].
The Genetic Connection
Both MDWH and CHH are caused by mutations (changes) in the RMRP gene, and they are inherited in an autosomal recessive pattern, meaning a child inherits one changed gene from each parent [1][3]. Because they share the same genetic root, researchers and doctors now view them as part of a single clinical spectrum rather than distinct diseases [1][2]. Even people with the exact same genetic mutation can have different symptoms—one sibling might have classic CHH while another has a presentation more like MDWH [2][4].
How Symptoms Differ Initially
When a child is first diagnosed, the main differences lie in what symptoms are immediately visible:
- Bone Growth: Both conditions involve metaphyseal dysplasia, which is a problem with the growing ends of the long bones (metaphyses) [1][5]. This usually results in short stature, bowed legs, and limited joint mobility [1][5].
- Hair: People with classic CHH have hypotrichosis, meaning their hair is sparse, thin, and light-colored [1]. In MDWH, hair growth is typically normal [1][2].
- Early Immune Function: Classic CHH often presents in infancy or early childhood with significant immune system problems, making the child prone to severe infections [6]. In contrast, people labeled with MDWH may not show obvious immune issues early in life [1].
Why Long-Term Monitoring is Crucial
The most important thing to know about MDWH is that having normal hair and a healthy immune system in childhood does not mean you are free from the other risks of CHH [1][2]. The symptoms of RMRP-related conditions can evolve over time [1].
- Immune System Changes: Over time, patients initially diagnosed with MDWH can develop clinically significant immunodeficiency (a weakened immune system) [1][7]. This can include problems with how white blood cells fight off infections, which requires careful tracking [1][6].
- Cancer Risk: Anyone with an RMRP gene mutation—whether diagnosed with CHH or MDWH—has an increased risk of developing certain cancers later in life [1][7]. This notably includes lymphomas (cancers of the lymphatic system) and non-melanoma skin cancers [1][7].
Because MDWH is part of the CHH spectrum, doctors now recommend that anyone diagnosed with MDWH receive the same thorough, long-term monitoring as someone with classic CHH [1][2]. You should discuss building a care team that might include an immunologist, an orthopedist, and a dermatologist.
Between typically annual check-ups, contact your healthcare team if you notice any of these warning signs:
- Infections that are unusually frequent, severe, or hard to cure
- Swollen lymph nodes (lumps under the skin in the neck, armpits, or groin)
- Unexplained weight loss, night sweats, or frequent fevers
- New or changing skin spots
Ongoing cancer screenings and immune evaluations—such as regular blood work to check white blood cell function, physical exams feeling for lymph nodes, and routine skin checks—are critical tools for staying ahead of these risks [1][7].
Common questions in this guide
What is the difference between MDWH and Cartilage-Hair Hypoplasia?
Are MDWH and Cartilage-Hair Hypoplasia completely different diseases?
Do people with MDWH still need cancer screenings?
Can my immune system change over time if I have MDWH?
Which doctors should be on my care team for MDWH?
Questions for Your Doctor
5 questions
- •Since my genetic results show an RMRP mutation but I have a normal hair presentation, how does this affect my overall risk profile?
- •What specific blood tests do you recommend doing annually to check for late-onset immune issues or bone marrow problems?
- •What specific physical exams or imaging will be used for ongoing cancer screening, particularly for lymphoma?
- •Are there any live vaccines that I or my child should avoid due to potential evolving immune deficiency?
- •Which medical specialists—such as an immunologist or dermatologist—should I proactively add to my core care team?
Questions for You
3 questions
- •Have I noticed any recent changes in how often I get sick or how long it takes me to fully recover from minor infections?
- •Are there any unusual symptoms, like unexplained night sweats, weight loss, or swollen lymph nodes, that I need to mention at my next appointment?
- •Do I have a system in place to track my recommended annual immune and cancer screenings?
References
References (7)
- 1
'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.
Vakkilainen S, Costantini A, Taskinen M, et al.
Journal of medical genetics 2020; (57(1)):18-22 doi:10.1136/jmedgenet-2019-106131.
PMID: 31413121 - 2
Cartilage-hair hypoplasia-anauxetic dysplasia spectrum disorders harboring RMRP mutations in two Korean children: A case report.
Park JH, Im M, Kim YJ, et al.
Medicine 2024; (103(21)):e37247 doi:10.1097/MD.0000000000037247.
PMID: 38787970 - 3
Homozygous n.64C>T mutation in mitochondrial RNA-processing endoribonuclease gene causes cartilage hair hypoplasia syndrome in two siblings.
Lugli L, Ciancia S, Bertucci E, et al.
European journal of medical genetics 2021; (64(2)):104136 doi:10.1016/j.ejmg.2021.104136.
PMID: 33444820 - 4
Cartilage-hair hypoplasia with normal height in childhood-4 patients with a unique genotype.
Klemetti P, Valta H, Kostjukovits S, et al.
Clinical genetics 2017; (92(2)):204-207 doi:10.1111/cge.12969.
PMID: 28094436 - 5
Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.
Riley P, Weiner DS, Leighley B, et al.
Journal of children's orthopaedics 2015; (9(2)):145-52 doi:10.1007/s11832-015-0646-z.
PMID: 25764362 - 6
[Cartilage-hair hypoplasia. A case report].
Staines-Boones TA, González-Villarreal MG, Hernández-Fernández C
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(3)):379-383 doi:10.29262/ram.v66i3.561.
PMID: 31606024 - 7
Cartilage hair hypoplasia with cutaneous lymphomatoid granulomatosis.
Sathishkumar D, Gach JE, Ogboli M, et al.
Clinical and experimental dermatology 2018; (43(6)):713-717 doi:10.1111/ced.13543.
PMID: 29744913
This page explains the differences between MDWH and Cartilage-Hair Hypoplasia for educational purposes. Always consult your genetics, immunology, or oncology care team regarding your specific genetic risks and long-term screening needs.
Get notified when new evidence is published on Cartilage-hair hypoplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.